ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Baxalta Incorporated

Baxalta Incorporated (BXLT)

46.02
0.00
(0.00%)
終値: 12月5日 6:00AM
46.02
0.00
( 0.00% )
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
46.02
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
46.02
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

BXLT 最新ニュース

Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions

Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions PR Newswire DUBLIN, June 3, 2016 DUBLIN, June 3, 2016 /PRNewswire/...

TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MD...

TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MDC Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK...

CORRECTING and REPLACING Baxalta Shareholders Vote to Approve Combination

First paragraph, second sentence of release should read: Baxalta shareholders approved the definitive merger agreement with Shire, dated as of January 11, 2016, and the merger transaction...

Baxalta Shareholders Vote to Approve Combination

Baxalta Incorporated (NYSE:BXLT) today announced the results of a vote on the proposals identified in the definitive proxy statement/prospectus, dated April 18, 2016, at a special meeting of...

OncoResponse Secures Investment from Baxalta

OncoResponse, an immuno-oncology antibody discovery company, today announced an investment from Baxalta Incorporated (NYSE: BXLT). In October 2015, OncoResponse closed a Series A financing...

Baxalta Reports Positive Phase 1 Results for BAX 930, Investigational Recombinant ADAMTS13 to Treat Hereditary Thrombotic Thr...

Single recombinant ADAMTS13 infusions demonstrated a favorable safety profile in adult and adolescent patients with severe hTTP hTTP is a rare blood clotting disease related to ADAMTS13...

Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Ph...

First company established under Vitesse Biologics, an innovative collaboration formed by Baxalta, Mayo Clinic and Velocity Pharmaceutical Development Thunderbolt Pharma, Inc., will...

Baxalta Announces Preliminary Merger Consideration Election Results

Baxalta Incorporated (NYSE:BXLT) today announced the preliminary results of the elections made by its stockholders as to the form of stock consideration to be received in Baxalta’s merger...

Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome i...

Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome injection) Regimen in Metastatic Colorectal Cancer Study to evaluate...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CHPTChargePoint Holdings Inc
US$ 1.35
(10.66%)
10.19M
EAFGrafTech International Ltd
US$ 2.1999
(10.00%)
2.78k
IDTIDT Corporation
US$ 54.00
(6.76%)
2.23k
NVRONevro Corp
US$ 4.39
(6.04%)
2.32k
CXMSprinklr Inc
US$ 9.13
(5.67%)
471.25k
AEOAmerican Eagle Outfitters Inc
US$ 17.7608
(-13.53%)
2.31M
SSentinelOne Inc
US$ 24.8507
(-13.35%)
4.24M
NMGNouveau Monde Graphite Inc
US$ 1.27
(-7.97%)
549
GEFGreif Inc
US$ 66.58
(-6.88%)
10.2k
PERFPerfect Corp
US$ 2.1634
(-6.35%)
600
CHPTChargePoint Holdings Inc
US$ 1.35
(10.66%)
10.19M
PCGPG&E Corporation
US$ 20.62
(0.49%)
6.68M
NIONIO Inc
US$ 4.61
(0.22%)
6.39M
YMMFull Truck Alliance Co Ltd
US$ 10.19
(-0.68%)
6.13M
BBAIBigBear ai Holdings Inc
US$ 2.63
(0.77%)
5.61M